microRNAs( miRNAs) are low-molecular-weight non-coding RNAs that regulate various physiological and pathological functions through the regulation of gene expression at the post-transcriptional level. More and more evidence has shown that microRNA-27 a( miRNA-27 a) plays a role in the development and pathogenesis of liver diseases. By reviewing and updating related studies,this article introduces the research advances in the role of miRNA-27 a in various liver diseases including fatty liver disease,hepatitis,hepatic fibrosis,and liver cancer and analyzes the role of miRNA-27 a in liver regeneration and its potential as a biomarker,so as to provide a reference for future studies and more possibilities for new treatment ideas for chronic hepatic diseases.
[1]MOHR AM,MOTT JL.Overview of microRNA biology[J].Semin Liver Dis,2015,35(1):3-11.
|
[2]KROL J,LOEDIGE I,FILIPOWICZ W.The widespread regulation of microRNA biogenesis,function and decay[J].Nat Rev Genet,2010,11(9):597-610.
|
[3]CHAKRABORTY C,SHARMA AR,SHARMA G,et al.Therapeutic miRNA and siRNA:Moving from bench to clinic as next generation medicine[J].Mol Ther Nucleic Acids,2017,8:132-143.
|
[4]CERMELLI S,RUGGIERI A,MARRERO JA,et al.Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease[J].PLo S One,2011,6(8):e23937.
|
[5]COBBINA E,AKHLAGHI F.Non-alcoholic fatty liver disease(NAFLD)-pathogenesis,classification,and effect on drug metabolizing enzymes and transporters[J].Drug Metab Rev,2017,49(2):197-211.
|
[6]ZHANG M,SUN W,ZHOU M,et al.MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1[J].Sci Rep,2017,7(1):14493.
|
[7]STRABLE MS,NTAMBI JM.Genetic control of de novo lipogenesis:Role in diet-induced obesity[J].Crit Rev Biochem Mol Biol,2010,45(3):199-214.
|
[8]DORN C,RIENER MO,KIROVSKI G,et al.Expression of fatty acid synthase in nonalcoholic fatty liver disease[J].Int J Clin Exp Pathol,2010,3(5):505-514.
|
[9]SINGH SB,KANG L,NAWROCKI AR,et al.Correction:The fatty acid synthase inhibitor platensimycin improves insulin resistance without inducing liver steatosis in mice and monkeys[J].PLo S One,2017,12(1):e0170721.
|
[10]LAI K,KWEON SM,CHI F,et al.Stearoyl-Co A desaturase promotes liver fibrosis and tumor development in mice via a wnt positivesignaling loop by stabilization of low-density lipoprotein-receptorrelated proteins 5 and 6[J].Gastroenterology,2017,152(6):1477-1491.
|
[11]YANG Q,ZHANG D,LI Y,et al.Paclitaxel alleviated liver injury of septic mice by alleviating inflammatory response via microRNA-27a/TAB3/NF-κB signaling pathway[J].Biomed Pharmacother,2018,97:1424-1433.
|
[12]CHOI JE,HUR W,KIM JH,et al.MicroRNA-27a modulates HCVinfection in differentiated hepatocyte-like cells from adipose tissuederived mesenchymal stem cells[J].PLo S One,2014,9(5):e91958.
|
[13]SHIRASAKI T,HONDA M,SHIMAKAMI T,et al.MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells[J].J Virol,2013,87(9):5270-5286.
|
[14]SAHA B,MOMEN-HERAVI F,KODYS K,et al.MicroRNA cargo of extracellular vesicles from alcohol-exposed monocytes signals naive monocytes to differentiate into M2 macrophages[J].J Biol Chem,2016,291(1):149-159.
|
[15]CAMPANA L,LREDALE JP.Regression of liver fibrosis[J].Semin Liver Dis,2017,37(1):1-10.
|
[16]ZOUBEK ME,TRAUTWEIN C,STRNAD P.Reversal of liver fibrosis:From fiction to reality[J].Best Pract Res Clin Gastroenterol,2017,31(2):129-141.
|
[17]JI J,ZHANG J,HUANG G,et al.Over-expressed microRNA-27a and27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation[J].FEBS Lett,2009,583(4):759-766.
|
[18]LIUZZI A,SAVIA G,TAGLIAFERRI M,et al.Serum leptin concentration in moderate and severe obesity:Relationship with clinical,anthropometric and metabolic factors[J].Int J Obes Relat Metab Disord,1999,23(10):1066-1073.
|
[19]LI Z,JI L,SU S,et al.Leptin up-regulates microRNA-27a/b-3p level in hepatic stellate cells[J].Exp Cell Res,2018,366(1):63-70.
|
[20]CHEN Z,MA T,HUANG C,et al.MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells[J].Cell Signal,2013,25(12):2693-2701.
|
[21]ZHAO N,SUN H,SUN B,et al.miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT:An essential role for Twist-1 in HCC[J].Sci Rep,2016,6:23091.
|
[22]TSENG JC,CHEN HF,WU KJ.A twist tale of cancer metastasis and tumor angiogenesis[J].Histol Histopathol,2015,30(11):1283-1294.
|
[23]SUN B,LI J,SHAO D,et al.Adipose tissue-secreted miR-27a promotes liver cancer by targeting FOXO1 in obese individuals[J].Onco Targets Ther,2015,8:735-744.
|
[24]CHEN Y,ZHANG F,ZHAO Y,et al.Obesity-associated miR-27a upregulation promotes hepatocellular carcinoma metastasis through suppressing SFRP1[J].Onco Targets Ther,2018,11:3281-3292.
|
[25]LAN X,LI G,LIU H,et al.MiR-27a/b regulates liver regeneration by posttranscriptional modification of tmub1[J].Dig Dis Sci,2018,63(9):2362-2372.
|
[26]ZHANG H,YAN XL,GUO XX,et al.MiR-27a as a predictor for the activation of hepatic stellate cells and hepatitis B virus-induced liver cirrhosis[J].Oncotarget,2018,9(1):1075-1090.
|
[27]TAK H,KANG H,JI E,et al.Potential use of TIA-1,MFF,microRNA-200a-3p,and microRNA-27 as a novel marker for hepatocellular carcinoma[J].Biochem Biophys Res Commun,2018,497(4):1117-1122.
|